The Asia Pacific Skin Cancer Market is expected to grow at a CAGR of 8.8% during forecasted period 2018-2023.
Some of key the players in the market are F. Hoffmann-la Roche Ltd. (Switzerland), Novartis International AG (Switzerland), Sun Pharma Industries Ltd. (India), Elekta AB (Sweden), Varian Medical Systems Inc. (US), Cannabis Science Inc. (US), Cellceutix Corp. (US), LEO Pharma A/S (Denmark), Moberg Pharma AB (Sweden), Mylan Pharmaceutical Inc. (US), Oncothyreon Inc. (US), Eli Lilly and Co. (US), Bristol Myers Squibb Co. (US), Boehringer Ingelheim GmbH (Germany), Aqua Pharmaceuticals LLC (US), Valeant Pharmaceuticals Inc (Canada), Meda AB (US), iCAD Inc. (Sweden), and Merck & Co. Inc. (US).
Skin cancer is the most common type of cancer, which arise due to uncontrolled growth of abnormal skin cells. It occurs when skin cells are damaged by unrepaired DNA or genetic defects that lead the uncontrolled growth of cells in the skin. Over 100 types of cancer are found across the globe but skin cancer is the most common form of cancer, which accounts for at least 30% of total cancer cases.
Get a Sample Copy of This Report @ https://www.marketresearchfuture.com/sample_request/1173 .
The prevalence of skin cancer is increasing owing to depleting ozone level and increasing solar UV radiation entering the Earth’s surface. According to the WHO, it is estimated that a 10% decrease in the ozone level is likely to result in an additional 300,000 non-melanoma and 4,500 melanoma skin cancer cases.
There are three major types of cancer: basal cell skin cancer (BCC), squamous-cell skin cancer (SCC) and melanoma. The basal cell skin cancer is the most common type of cancer. The major cause of the skin cancer is overexposure to harmful radiation and HPV infections, which increases the risk of skin cancer. The major driving factor for the growth of the market is increasing the prevalence of skin cancer. Furthermore, extensive R&D pipelines and increasing usage of combination therapies have fueled the growth of the market. On another hand, stringent regulatory guidelines, side effects associated with the treatment and long approval time for the drugs may hamper the growth of the market over the review period.
On the regional basis, Asia Pacific market is segmented into Japan, India, China, the Republic of Korea, Australia, and the Rest of Asia Pacific.
Asia Pacific is the fastest growing skin cancer market. Japan, Australia, and China are the major contributor to the market growth. The incidence of skin cancer per 100,000 population is 20-25 cases in Japan, 11-12 cases in China. About 80% of the cases are basal cell carcinoma (BCC), 16% squamous cell carcinoma, and 4% are melanoma.
Get Attractive Discount on This Report @ https://www.marketresearchfuture.com/check-discount/1173 .
Continuously increasing the prevalence of skin cancer in Japan is driving the growth of this region. Furthermore, increasing government support for research and continuous development in technology is an important driving factor for the growth of the Asia Pacific market.
1 Report Prologue
2.2 Scope of the Study
2.3 Research Objective
2.6 Market Structure
2.7 Market Segmentation
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
LIST OF TABLES
Table 1 Skin Cancer Industry Synopsis, 2017-2023
Table 2 Asia Pacific Skin Cancer Market Estimates and Forecast, 2017-2023, (USD Million)
Table 3 Asia Pacific Skin Cancer Market by Country, 2017-2023, (USD Million)
Table 4 Asia Pacific Skin Cancer Market by Types, 2017-2023, (USD Million)
Table 5 Asia Pacific Skin Cancer Market by Treatment, 2017-2023, (USD Million)
Table 7 Asia Pacific Skin Cancer Market by End Users, 2017-2023, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Asia Pacific Skin Cancer Market
Figure 3 Segmentation Market Dynamics for Skin Cancer Market
Figure 4 Asia Pacific Skin Cancer Market Share, by Types 2016
Figure 5 Asia Pacific Skin Cancer Market Share, by Treatment 2016
Figure 6 Asia Pacific Skin Cancer Market Share, by End Users, 2016
Inquire about This Report @ https://www.marketresearchfuture.com/enquiry/1173 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312